These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6196070)

  • 21. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS; Goldman-Rakic PS
    J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
    Guldberg HC; Yates CM
    Br J Pharmacol; 1969 Jul; 36(3):535-48. PubMed ID: 5789808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of (+)-amphetamine, alpha-methyltyrosine, and alpha-methylphenylalanine on the concentrations of m-tyramine and alpha-methyl-m-tyramine in rat striatum.
    Dougan DF; Duffield AM; Duffield PH; Wade DN
    Br J Pharmacol; 1983 Oct; 80(2):309-14. PubMed ID: 6652380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct effect of neuroleptics on glutamate release.
    Sherman AD; Mott J
    Neuropharmacology; 1984 Nov; 23(11):1253-9. PubMed ID: 6084822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of drugs used in psychoses on cerebral dopamine metabolism.
    O'Keeffe R; Sharman DF; Vogt M
    Br J Pharmacol; 1970 Feb; 38(2):287-304. PubMed ID: 4984801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chronic and acute treatment of antipsychotic drugs on calmodulin release from rat striatal membranes.
    Gnegy ME; Lau YS
    Neuropharmacology; 1980 Mar; 19(3):319-23. PubMed ID: 6158710
    [No Abstract]   [Full Text] [Related]  

  • 28. Blockade of the dopamine depressor response by molindone, a newly introduced neuroleptic.
    Nandal NV; Mane VR; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(2):143-7. PubMed ID: 6103868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain.
    Bissette G; Dauer WT; Kilts CD; O'Connor L; Nemeroff CB
    Neuropsychopharmacology; 1988 Dec; 1(4):329-35. PubMed ID: 2472151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptics and learning: effects of haloperidol, molindone, mesoridazine and thioridazine on the behavior of pigeons under a repeated acquisition procedure.
    Poling A; Cleary J; Berens K; Thompson T
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1240-5. PubMed ID: 1979814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic-induced seizures. An in vitro technique for assessing relative risk.
    Oliver AP; Luchins DJ; Wyatt RJ
    Arch Gen Psychiatry; 1982 Feb; 39(2):206-9. PubMed ID: 6175290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation.
    Bastianetto S; Danik M; Mennicken F; Williams S; Quirion R
    BMC Neurosci; 2006 Mar; 7():28. PubMed ID: 16573831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of benzene and other organic solvents on the decarboxylation of some brain aromatic-L-amino acids.
    Juorio AV; Yu PH
    Biochem Pharmacol; 1985 May; 34(9):1381-7. PubMed ID: 3994754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
    J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens.
    Zivkovic B; Guidotti A; Revuelta A; Costa E
    J Pharmacol Exp Ther; 1975 Jul; 194(1):37-46. PubMed ID: 239221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
    Kobayashi T; Shimizu H; Toru M
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of psychotropic drugs on lateral hypothalamic self-stimulation behavior in rats: correlation between self-stimulation behavior inhibition and striatal dopaminergic blockade by neuroleptic drugs].
    Fukuda T; Tsumagari T
    Nihon Yakurigaku Zasshi; 1984 Jun; 83(6):485-96. PubMed ID: 6149172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.